{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:41:19Z","timestamp":1777927279147,"version":"3.51.4"},"reference-count":15,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>A trend of increased adverse effects and laboratory abnormalities was observed in patients treated at the University of Illinois Hospital and Health Sciences System (UIH) HIV Telemedicine Clinic after switching to abacavir\/dolutegravir\/lamivudine (ABC\/DTG\/3TC). Therefore, we sought to investigate if major clinical trials overestimated the safety and tolerability of DTG-based antiretroviral therapy (ART). This study was a single-center, retrospective, pre- and post-analysis of incarcerated patients receiving care at the UIH HIV Telemedicine Clinic, USA. Patients included were adults with HIV switched from previous ART to ABC\/DTG\/3TC. Primary endpoints included patient-reported adverse effects and changes in renal and hepatic function from baseline. A total of 95 patients were included in the study. After switching from previous ART to ABC\/DTG\/3TC, 20% of patients reported incidence of adverse effects. Most common were headache (7.4%), nausea (6.3%) rash (3.2%), fatigue (3.2%), and insomnia (2.1%). There were statistically significant increases in serum creatinine (SCr), in 20% of the patients (P\u2009&lt;\u20090.0001), with a median increase of 0.38\u2009mg\/dl. ABC\/DTG\/3TC appears to have similar or fewer adverse effects in the real-world incarcerated population compared to clinical trials. DTG-based ART can cause statistically significant increases in SCr in some patients.<\/jats:p>","DOI":"10.1177\/0956462419863925","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T03:20:52Z","timestamp":1569554452000},"page":"1163-1168","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world evaluation of the safety and tolerability of abacavir\/dolutegravir\/lamivudine in an incarcerated population"],"prefix":"10.1177","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6986-2042","authenticated-orcid":false,"given":"Marisa B","family":"Brizzi","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-4391","authenticated-orcid":false,"given":"Thomas D","family":"Chiampas","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1182-7997","authenticated-orcid":false,"given":"Sarah M","family":"Michienzi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy D","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Immunology and Internal Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh C","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Immunology and Internal Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa E","family":"Badowski","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"bibr1-0956462419863925","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV, https:\/\/aidsinfo.nih.gov\/guidelines (accessed 17 December 2018)."},{"key":"bibr2-0956462419863925","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.8431"},{"key":"bibr3-0956462419863925","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215541"},{"key":"bibr4-0956462419863925","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu051"},{"key":"bibr5-0956462419863925","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61221-0"},{"key":"bibr6-0956462419863925","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70290-0"},{"key":"bibr7-0956462419863925","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61853-4"},{"key":"bibr8-0956462419863925","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/S2352-3018(18)30092-4","volume":"5","author":"Molina JM","year":"2018","journal-title":"Lancet HIV"},{"key":"bibr9-0956462419863925","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury.\n                      Kidney inter\n                      Suppl. 2012; 2: 1-138."},{"key":"bibr10-0956462419863925","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"bibr11-0956462419863925","unstructured":"Ziagen (abacavir) (package insert). Research Triangle Park, NC: GlaxoSmithKline, 2008."},{"key":"bibr12-0956462419863925","unstructured":"Tivicay (dolutegravir) (package insert). Research Triangle Park, NC: ViiV Healthcare, 2013."},{"key":"bibr13-0956462419863925","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001557"},{"key":"bibr14-0956462419863925","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04440.x"},{"key":"bibr15-0956462419863925","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ndt\/gfx160.MP016","volume":"32","author":"Milburn J","year":"2017","journal-title":"Nephrol Dial Transplant"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462419863925","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0956462419863925","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462419863925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:39:42Z","timestamp":1777675182000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0956462419863925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1177\/0956462419863925"],"URL":"https:\/\/doi.org\/10.1177\/0956462419863925","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}